Curanex Pharmaceuticals Inc (CURX) Price Prediction & ForecastCURXCuranex Pharmaceuticals Inc

Alphio's CURX stock price prediction model matches the current Curanex Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.76 (+4.37%). The 1-week path is $5.65 (+23.86%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Curanex Pharmaceuticals Inc is currently not a strong buy due to its negative financial performance and market sentiment. The stock is trading at $4.56, down 38.09% year-to-date, and has a 1-year change of -96.11%. While there was a recent positive catalyst regarding a patient case study that showed improvements with their product Phyto-N, the overall financials show a troubling trend with a forward P/E of 0 and consistent net losses, including a net income loss of $3,290,970 in Q2 2026. The main risk is the ongoing negative earnings trend, as indicated by the EPS of -2.32 for Q2 2026. Investors should monitor for any further developments before making a buying decision.

Curanex Pharmaceuticals Inc (CURX) last closed at $4.56, losing -2.56%. These facts feed the 1-day and 1-week CURX price prediction above.